Organovo Holdings, Inc. (ONVO) Shares Sold by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. trimmed its stake in shares of Organovo Holdings, Inc. (NASDAQ:ONVO) by 20.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,970 shares of the medical research company’s stock after selling 19,820 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Organovo Holdings were worth $197,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Voya Investment Management LLC increased its position in Organovo Holdings by 18.8% in the 2nd quarter. Voya Investment Management LLC now owns 52,032 shares of the medical research company’s stock valued at $137,000 after acquiring an additional 8,225 shares during the period. Lehman Financial Resources Inc. increased its position in Organovo Holdings by 21.8% in the 2nd quarter. Lehman Financial Resources Inc. now owns 178,900 shares of the medical research company’s stock valued at $472,000 after acquiring an additional 32,000 shares during the period. Ark Investment Management LLC increased its position in Organovo Holdings by 134.5% in the 2nd quarter. Ark Investment Management LLC now owns 1,445,039 shares of the medical research company’s stock valued at $3,800,000 after acquiring an additional 828,787 shares during the period. Vanguard Group Inc. increased its position in Organovo Holdings by 5.2% in the 2nd quarter. Vanguard Group Inc. now owns 4,470,182 shares of the medical research company’s stock valued at $11,756,000 after acquiring an additional 220,165 shares during the period. Finally, Northern Trust Corp increased its position in Organovo Holdings by 2.1% in the 2nd quarter. Northern Trust Corp now owns 1,199,998 shares of the medical research company’s stock valued at $3,156,000 after acquiring an additional 24,408 shares during the period. Institutional investors and hedge funds own 26.84% of the company’s stock.

Shares of Organovo Holdings, Inc. (NASDAQ:ONVO) opened at $1.54 on Tuesday. Organovo Holdings, Inc. has a 12 month low of $1.32 and a 12 month high of $4.08.

Organovo Holdings (NASDAQ:ONVO) last posted its quarterly earnings data on Thursday, November 9th. The medical research company reported ($0.09) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.10) by $0.01. Organovo Holdings had a negative net margin of 923.89% and a negative return on equity of 65.63%. The company had revenue of $1.36 million for the quarter, compared to analyst estimates of $1.38 million. Organovo Holdings’s quarterly revenue was down 1.4% on a year-over-year basis. research analysts expect that Organovo Holdings, Inc. will post -0.36 earnings per share for the current fiscal year.

Several equities analysts have issued reports on the stock. Jefferies Group LLC restated a “buy” rating and issued a $4.00 price target on shares of Organovo Holdings in a research report on Tuesday, September 26th. Zacks Investment Research upgraded shares of Organovo Holdings from a “hold” rating to a “buy” rating and set a $2.25 price target for the company in a research report on Wednesday, October 11th. Raymond James Financial, Inc. cut shares of Organovo Holdings from an “outperform” rating to a “market perform” rating and set a $5.00 price target for the company. in a research report on Friday, November 10th. BTIG Research restated a “buy” rating and issued a $3.00 price target on shares of Organovo Holdings in a research report on Thursday, November 16th. Finally, Citigroup Inc. cut shares of Organovo Holdings to a “market perform” rating in a research report on Friday, November 10th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $3.60.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://sportsperspectives.com/2017/11/21/organovo-holdings-inc-onvo-shares-sold-by-goldman-sachs-group-inc.html.

About Organovo Holdings

Want to see what other hedge funds are holding ONVO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Organovo Holdings, Inc. (NASDAQ:ONVO).

Institutional Ownership by Quarter for Organovo Holdings (NASDAQ:ONVO)

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply